Meda AB Acquires Acton Pharmaceuticals for $145,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1c1ee53d-fb02-4a99-af2e-4eda1aa93391
Date
8/30/2013
Company Name
Acton Pharmaceuticals
Mailing Address
225 Cedar Hill Street Marlborough, MA 01752
Company Description
Acton is primarily focused on development and commercialization of innovative pharmaceutical products that treat allergic, pulmonary, and other respiratory related diseases.
Website
http://www.actonpharmaceuticals.com
Transaction Type
M&A
Transaction Amount
$145,000,000
Transaction Round
Proceeds Purposes
M&A Terms
The purchase price for Acton amounts to 135 million USD. In addition, there is a milestone payment of 10 million USD and royalty based milestones.